AWARDPURCHASE ORDERSmall business
Purchase order 75N93022P00014BIO X CELL, LLC
Overview
Award facts
- Net obligations
- $13.75K
- $13,750of $13.75K potential value
- Outlays (paid to date)
- $13.72K
- $13.72K paid of $13.75K obligated$13,720
- Period of performance
- Oct 18, 2021 to Oct 27, 2021
- Ended
- Modifications
- 0
- Latest action Oct 18, 2021
- Contract type
- Purchase order
- PIID 75N93022P00014
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
FOR COVID-19 RESEARCH, FOR COVID-19 RESEARCH, INVIVOMAB ANTI-MOUSE PD-L1 (1000 MG), CATALOG# BE0101, QUANTITY: 1 @ #13,650.00 EA.
Dates and value
- Award date
- Signed on Oct 18, 2021
- Potential end of performance
- Oct 26, 2021
- Current value
- $13,750Base and exercised options
- Potential value (if all options are exercised)
- $13,750
Obligations by fiscal year of action
- FY2022: $13,750
Total across 1 fiscal year: $13,750
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Oct 18, 2021. View on USAspending · Recipient on SAM.gov
Recipient
NameBIO X CELL, LLC
LocationWEST LEBANON, NH
UEIRCAAGKSC77R3
CAGE code1QV69
Business sizeSmall businessSize at award, per the contracting officer
Parent companyBIO X CELL, LLC
Business types and certifications
For-profit organizationSubchapter S corporation
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded from
- National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)
Place of performance
- Place of performance
- West Lebanon, Grafton County, New Hampshire 03784-1693
- Congressional district (place of performance)
- NH-02As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- 6505DRUGS AND BIOLOGICALS (product)
Competition
- Extent competed
- Not competed under SAPG
- Reason not competed
- Less than or equal to the micro-purchase thresholdMPT
- Solicitation procedures
- Simplified acquisitionSP1
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Contract details
- Subcontracting plan
- Plan not requiredB
- Commercial procedures
- Commercial itemA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Oct 18, 2021Base obligation at award: $13,750
- Latest action
- Oct 18, 2021 — Base awardModification 0; obligation change +$13,750
- Actions by type
- Base award1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- $13,750
- Latest action: change in base and all options
- $13,750
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- National interest action
- COVID-19 2020P20C
- Contingency, humanitarian or peacekeeping operation
- Presidential issued emergency declaration, or a major disaster declarationC
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Mfg in U.S.D
Structure
- Award or IDV
- Award
- Award type
- Purchase orderB
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N930
- Transactions recorded under this award key
- 1
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N930
- Treasury accounts
- 075-2020/2024-0885-000
- Object classes
- 22.0: Transportation of things
- 26.0: Supplies and materials
- Disaster or emergency funding (DEFC)
- L: Emergency P.L. 116-123
- COVID-19 supplemental obligations
- $13,720
- COVID-19 supplemental outlays
- $13,720